Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Landscape of the Plasmodium Interactome Reveals Both Conserved and Species-Specific Functionality.

Hillier C, Pardo M, Yu L, Bushell E, Sanderson T, Metcalf T, Herd C, Anar B, Rayner JC, Billker O, Choudhary JS.

Cell Rep. 2019 Aug 6;28(6):1635-1647.e5. doi: 10.1016/j.celrep.2019.07.019.

2.

Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes.

Bushell E, Gomes AR, Sanderson T, Anar B, Girling G, Herd C, Metcalf T, Modrzynska K, Schwach F, Martin RE, Mather MW, McFadden GI, Parts L, Rutledge GG, Vaidya AB, Wengelnik K, Rayner JC, Billker O.

Cell. 2017 Jul 13;170(2):260-272.e8. doi: 10.1016/j.cell.2017.06.030.

3.

A genome-scale vector resource enables high-throughput reverse genetic screening in a malaria parasite.

Gomes AR, Bushell E, Schwach F, Girling G, Anar B, Quail MA, Herd C, Pfander C, Modrzynska K, Rayner JC, Billker O.

Cell Host Microbe. 2015 Mar 11;17(3):404-413. doi: 10.1016/j.chom.2015.01.014. Epub 2015 Feb 26.

4.

PlasmoGEM, a database supporting a community resource for large-scale experimental genetics in malaria parasites.

Schwach F, Bushell E, Gomes AR, Anar B, Girling G, Herd C, Rayner JC, Billker O.

Nucleic Acids Res. 2015 Jan;43(Database issue):D1176-82. doi: 10.1093/nar/gku1143.

5.

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.

Bauza K, Malinauskas T, Pfander C, Anar B, Jones EY, Billker O, Hill AV, Reyes-Sandoval A.

Infect Immun. 2014 Mar;82(3):1277-86. doi: 10.1128/IAI.01187-13. Epub 2013 Dec 30.

6.

Recombination-mediated genetic engineering of Plasmodium berghei DNA.

Pfander C, Anar B, Brochet M, Rayner JC, Billker O.

Methods Mol Biol. 2013;923:127-38.

PMID:
22990774
7.

A scalable pipeline for highly effective genetic modification of a malaria parasite.

Pfander C, Anar B, Schwach F, Otto TD, Brochet M, Volkmann K, Quail MA, Pain A, Rosen B, Skarnes W, Rayner JC, Billker O.

Nat Methods. 2011 Oct 23;8(12):1078-82. doi: 10.1038/nmeth.1742.

8.

Familial aggregation of parkinsonism in progressive supranuclear palsy.

Donker Kaat L, Boon AJ, Azmani A, Kamphorst W, Breteler MM, Anar B, Heutink P, van Swieten JC.

Neurology. 2009 Jul 14;73(2):98-105. doi: 10.1212/WNL.0b013e3181a92bcc. Epub 2009 May 20.

PMID:
19458322
9.

Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.

Macedo MG, Verbaan D, Fang Y, van Rooden SM, Visser M, Anar B, Uras A, Groen JL, Rizzu P, van Hilten JJ, Heutink P.

Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287.

PMID:
18973254
10.

Distinct genetic forms of frontotemporal dementia.

Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, Maat-Kievit JA, Anar B, Donker Kaat L, Breedveld GJ, Dooijes D, Rozemuller JM, Bronner IF, Rizzu P, van Swieten JC.

Neurology. 2008 Oct 14;71(16):1220-6. doi: 10.1212/01.wnl.0000319702.37497.72. Epub 2008 Aug 13.

PMID:
18703462
11.

Progranulin mutations in Dutch familial frontotemporal lobar degeneration.

Bronner IF, Rizzu P, Seelaar H, van Mil SE, Anar B, Azmani A, Donker Kaat L, Rosso S, Heutink P, van Swieten JC.

Eur J Hum Genet. 2007 Mar;15(3):369-74. Epub 2007 Jan 17.

12.

CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia.

Rizzu P, van Mil SE, Anar B, Rosso SM, Donker Kaat L, Heutink P, van Swieten JC.

Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):944-6.

PMID:
16941655
13.

The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes.

Macedo MG, Anar B, Bronner IF, Cannella M, Squitieri F, Bonifati V, Hoogeveen A, Heutink P, Rizzu P.

Hum Mol Genet. 2003 Nov 1;12(21):2807-16. Epub 2003 Sep 2.

PMID:
12952867
14.

Screening for the fragile X syndrome among mentally retarded males by hair root analysis.

Tunçbilek E, Alikasifoğlu M, Aktas D, Duman F, Yanik H, Anar B, Oostra B, Willemsen R.

Am J Med Genet. 2000 Nov 13;95(2):105-7.

PMID:
11078558
15.

Clinical and genetic correlate in childhood onset Friedreich ataxia.

Alikaşifoglu M, Topaloglu H, Tunçbilek E, Ceviz N, Anar B, Demir E, Ozme S.

Neuropediatrics. 1999 Apr;30(2):72-6.

PMID:
10401688
16.

Noninvasive test for fragile X syndrome, using hair root analysis.

Willemsen R, Anar B, De Diego Otero Y, de Vries BB, Hilhorst-Hofstee Y, Smits A, van Looveren E, Willems PJ, Galjaard H, Oostra BA.

Am J Hum Genet. 1999 Jul;65(1):98-103.

17.

Frequency of fragile X syndrome among Turkish patients with mental retardation of unknown etiology.

Tunçbilek E, Alikasifoğlu M, Boduroğlu K, Aktas D, Anar B.

Am J Med Genet. 1999 May 28;84(3):202-3. No abstract available.

PMID:
10331591
18.

Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.

Tamanini F, Bontekoe C, Bakker CE, van Unen L, Anar B, Willemsen R, Yoshida M, Galjaard H, Oostra BA, Hoogeveen AT.

Hum Mol Genet. 1999 May;8(5):863-9.

PMID:
10196376
19.

Association of the 677C-->T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects.

Boduroğlu K, Alikaşifoğlu M, Anar B, Tunçbilek E.

J Child Neurol. 1999 Mar;14(3):159-61.

PMID:
10190266
20.

677-->CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey.

Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E.

Arch Dis Child Fetal Neonatal Ed. 1998 May;78(3):F235. No abstract available.

21.

Angiotensin converting enzyme gene polymorphism and the risk and extent of ischemic heart disease among Turkish patients.

Tokgözoğlu SL, Alikaşifoğlu M, Atalar E, Tunçbilek E, Ovünç K, Aksöyek S, Kabakçi G, Anar B, Unsal I, Kes S.

Coron Artery Dis. 1997 Mar-Apr;8(3-4):137-41.

PMID:
9237022

Supplemental Content

Support Center